{
    "medicine_id": "eed9f5068e893f364d786264dfbe45d99f6cc2f1",
    "platform_id": "DB14569",
    "metadata": {
        "name": "Tibsovo 250 mg 1 Tablet film coated",
        "composition": "250 mg 1 Tedizolid",
        "clinical_particulars": {
            "therapeutic_indications": "Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure ABSSSI To prevent drug resistance tedizolid should only be used for infections that are caused by susceptible bacteria L11232",
            "contraindications": {
                "disease": "Toxicity information regarding tedizolid is not readily available Patients experiencing an overdose are at an increased risk of severe adverse effects such as nausea headache dizziness diarrhea and vomiting Symptomatic and supportive measures are recommended L11232",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Tedizolid is an oxazolidinone antibiotic that works by inhibiting protein synthesis by bacterial ribosomes L11232 A199077 A199086 However oxazolidinone antibiotics can also bind to human mitochondrial but not cytoplasmic ribosomes A199080 A199092 Mitochondrial protein synthesis inhibition is associated with adverse patient effects such as neurological hematological and gastrointestinal toxicity although tedizolid is tolerated better than the related linezolid A199050 Alternative therapies should be considered when treating neutropenic patients with ABSSSI _Clostridium difficile_ associated diarrhea has been reported in patients treated with tedizolid L11232",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Tedizolid"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Tedizolid"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Tedizolid"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Tedizolid is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Tedizolid"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Tedizolid"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}